Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (1-10 of 395) with videos related to

Pageof 40
Sort By:
Clinical Chemistry and Laboratory Medicine|February 10, 2011
CSF biomarkers in neurodegenerative diseasesNiklas Mattsson
Lakartidningen|March 5, 2013
["Fight against aging as a disease"]Niklas Mattsson
Brain : a Journal of Neurology|July 17, 2024
Disentangling genetic risks for development and progression of Alzheimer's diseaseNiklas Mattsson-Carlgren
Brain : a Journal of Neurology|August 12, 2025
Plasma biomarker profiles in ageing: decoding neurodegeneration in vivoNiklas Mattsson-Carlgren
Expert Review of Neurotherapeutics|May 24, 2014
Understanding the cause of sporadic Alzheimer's diseaseHenrik Zetterberg, Niklas Mattsson
Nature Reviews. Neurology|June 30, 2019
Primary fatty amides are potential plasma biomarkers for ADNiklas Mattsson, Oskar Hansson
European Neurology|July 16, 2009
Future screening for incipient Alzheimer's disease--the influence of prevalence on test performanceNiklas Mattsson, Henrik Zetterberg
Biomarkers in Medicine|May 19, 2010
Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applicationsNiklas Mattsson, Henrik Zetterberg
Biomarkers in Medicine|August 25, 2012
What is a certified reference material?Niklas Mattsson, Henrik Zetterberg
Brain : a Journal of Neurology|April 5, 2023
The emerging era of staging Alzheimer's disease pathology using plasma biomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist
Pageof 40

Showing results (1-10 of 395) with videos related to

Sort By:
Pageof 40
Clinical Chemistry and Laboratory Medicine|February 10, 2011
CSF biomarkers in neurodegenerative diseasesNiklas Mattsson
Lakartidningen|March 5, 2013
["Fight against aging as a disease"]Niklas Mattsson
Brain : a Journal of Neurology|July 17, 2024
Disentangling genetic risks for development and progression of Alzheimer's diseaseNiklas Mattsson-Carlgren
Brain : a Journal of Neurology|August 12, 2025
Plasma biomarker profiles in ageing: decoding neurodegeneration in vivoNiklas Mattsson-Carlgren
Expert Review of Neurotherapeutics|May 24, 2014
Understanding the cause of sporadic Alzheimer's diseaseHenrik Zetterberg, Niklas Mattsson
Nature Reviews. Neurology|June 30, 2019
Primary fatty amides are potential plasma biomarkers for ADNiklas Mattsson, Oskar Hansson
European Neurology|July 16, 2009
Future screening for incipient Alzheimer's disease--the influence of prevalence on test performanceNiklas Mattsson, Henrik Zetterberg
Biomarkers in Medicine|May 19, 2010
Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applicationsNiklas Mattsson, Henrik Zetterberg
Biomarkers in Medicine|August 25, 2012
What is a certified reference material?Niklas Mattsson, Henrik Zetterberg
Brain : a Journal of Neurology|April 5, 2023
The emerging era of staging Alzheimer's disease pathology using plasma biomarkersNiklas Mattsson-Carlgren, Sebastian Palmqvist
Pageof 40